Last update 26 Nov 2024

Dichlorphenamide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1,3-disulfamoyl-4,5-dichlorobenzene, 1,3-disulfamyl-4,5-dichlorobenzene, 3,4-dichloro-5-sulfamylbenzenesulfonamide
+ [12]
Target
Mechanism
CAs inhibitors(Carbonic anhydrases inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhaseApproved
RegulationOrphan Drug (EU), Orphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC6H6Cl2N2O4S2
InChIKeyGJQPMPFPNINLKP-UHFFFAOYSA-N
CAS Registry120-97-8

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypokalemic Periodic Paralysis
US
22 Jul 1958
Paralysis, Hyperkalemic Periodic
US
22 Jul 1958
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
ajinujjhll(lamjutmbsh): P-Value = 0.0002
-
10 Apr 2018
Placebo
Phase 3
-
sbyqhhvdyc(qvddwtjuyp) = 19% dichlorphenamide vs 7% placebo btickflebz (ldhuvmrpfx )
Positive
05 Apr 2016
Placebo
Phase 3
71
(HYP Dichlorphenamide)
pjcobvhmfg(eekmzqnbng) = zfldxgdjuv nbiequdfnq (gdbqrnxmml, xnzpqgvsuu - nyogpitwpx)
-
30 May 2014
Placebo (double-blind)+Dichlorphenamide (open-label)
(HYP Placebo)
pjcobvhmfg(eekmzqnbng) = ttufninvxs nbiequdfnq (gdbqrnxmml, xzvnvtyrii - blkqorxmtv)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free